Séamus O’Reilly MDPhD
@seamusoreilly.bsky.social
270 followers 550 following 16 posts
Medical Oncologist Clinical Lead Cancer Trials Ireland Member, Exec Board, Breast International Group Deputy Editor BJC Reports Member, ESMO Climate Change Task Force
Posts Media Videos Starter Packs
Reposted by Séamus O’Reilly MDPhD
ouchinternational.bsky.social
🌍 New in ecancermedicalscience: Climate change & cancer care shows how climate, pollution & biodiversity loss disrupt oncology + offers solutions. With OUCH members @roselledeguzman.bsky.social, Joan Schiller, Katie Lichter, & Seamus O'Reilly.

Read here: ecancer.org/en/journal/a...
seamusoreilly.bsky.social
Grateful to @londonglobalcancer.bsky.social for facilitating this @ouchinternational.bsky.social collaborative webinar on the impacts of #climatechange in 🇧🇷🇳🇬🇵🇭& ♻️sustainable healthcare solutions

🙏 to co✍️ incl @roselledeguzman.bsky.social & @cancertrialsie.bsky.social for hosting

Manuscript 🗒️👇
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
🌍♻️ New research from Cancer Trials Ireland explores how we can make cancer clinical trials more sustainable @aclaytonlea.bsky.social@seamusoreilly.bsky.social

Open access: bit.ly/4fsCBTa

#CancerTrials #Sustainability #ClimateAndHealth #GreenerTrials
Reposted by Séamus O’Reilly MDPhD
danielnuzum.bsky.social
‘Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre’ published online today.
A good example of integrated and committed MDT working to improve patient care and experience
@seamusoreilly.bsky.social @cancerresearch-ucc.bsky.social

www.mdpi.com/1718-7729/32...
seamusoreilly.bsky.social
I think the changes that allow great equity of access such as digital tools and the programme to ensure diversity. The strong patient partner element is also an exemplar
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
Powerful Irish Examiner piece on the toll of MBC across the island of 🇮🇪 featuring research by Siobhan Gaynor & Ann McBrien, with CTI Clinical Lead @seamusoreilly.bsky.social

📰 bit.ly/4o0OvaH

#MBC #BreastCancer #BMJOpenQuality #HealthEquity
Three out of five breast cancer patients in Republic face financial and mental stress
Ninety per cent of patients in the North and 86% in the Republic suffering mental stress
bit.ly
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
A new study led by @siobhangaynor.bsky.social & Ann McBrien with @seamusoreilly.bsky.social & supported by CTI, explores how people with metastatic breast cancer experience care across the island of Ireland: bit.ly/3IIZzZS

Real opportunities for bi-directional learning to improve care for all.
Reposted by Séamus O’Reilly MDPhD
bigxresearch.bsky.social
📢 New open-access article in npj Breast Cancer, co-authored by BIG’s leadership, explores the challenges of academic clinical trials and how to ensure their future impact.

📄 Read more: www.nature.com/articles/s41... #BIGAgainstBreastCancer #breastcancer #research
seamusoreilly.bsky.social
🙋‍♂️ How can we 📈 access to innovation for ALL patients with breast caner ❓
@bigxresearch.bsky.social commentary 📝👇

www.nature.com/articles/s41...

🙏 to co-authors✍️

Successes of the past ✅
Pitfalls of the present ✅
Solutions for the future eg OptimaYoung 👇
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
The 2025 Cancer Retreat Report is now available. This report reflects discussions from our May meeting at RCSI Dublin, highlighting key insights on HRB grants, career pathways, and digital infrastructure.

Read here: bit.ly/3Tw4Whj

#CancerTrialsIreland #Collaboration @seamusoreilly.bsky.social
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
1 week to go! Join Irish & global experts for the ISMO After-ASCO 2025 virtual update.

Tues, 15 July, 6–8 PM | Free & online

Open to clinicians, nurses, researchers, patients & industry.

Register now to get the meeting link: bit.ly/4mSF64s

@seamusoreilly.bsky.social
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
We welcome the new DPIA guidance for clinical trials from the National Clinical Trials Oversight Group, a valuable step toward clarity and consistency in trial setup: bit.ly/4emIaCh

👏Thanks to all involved.

#ClinicalTrials #DataProtection @roinnslainte.bsky.social @seamusoreilly.bsky.social
Outputs of the National Clinical Trials Oversight Group
www.gov.ie
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
Missed the 2025 #CancerRetreat or had to step out early?

All session recordings are now available on our YouTube playlist – a chance to catch up on key talks and discussions.

📺 Watch here: bit.ly/44cubLE

#CancerResearch #ClinicalTrials @seamusoreilly.bsky.social
Reposted by Séamus O’Reilly MDPhD
bigxresearch.bsky.social
The voice of Early Career Investigators is heard at the #BIG-NCTN Annual Meetings, Drs @darioT_ and @io_zerdes are speaking on the need for #younginvestigators ' involvement and support in patient-centered #clinicalresearch. @theNCI @bcrfcure.bsky.social
Reposted by Séamus O’Reilly MDPhD
bigxresearch.bsky.social
We are thrilled to announce a new collaboration with @paige_ai , leaders in AI-driven cancer digital pathology. Our partnership aims to combine BIG’s clinical trial expertise & data w Paige's AI capabilities to revolutionize #breastcancer research & care 🔗 bit.ly/4kzSsBd
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
📅 Mark your calendar: ISMO After ASCO 2025

A virtual meeting to share key insights from #ASCO25.

🗓️ Tuesday 15 July | 6–8PM Irish time
💻 Supported by Cancer Trials Ireland

🔗 Register now: www.eventbrite.com/e/ismo-after...

@seamusoreilly.bsky.social
ISMO after ASCO 2025
Virtual meeting to share updates from ASCO Annual Meeting
www.eventbrite.com
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
Behind every breakthrough is a clinical trial.

At Cancer Trials Ireland, we help turn questions into better answers.

🎥 Watch our brand video
🗓️ Join our public webinar today: bit.ly/4jvt9Q5

#InternationalClinicalTrialsDay #CancerTrialsIreland #ClinicalTrials #CancerResearch #Webinar
seamusoreilly.bsky.social
#ESMOBreast25
👏👏👏 @cancerresearch-ucc.bsky.social Academic Intern Dr Clara Steele

High levels of interest & engagement among ☘️ breast cancer patients for Secondary Risk Reduction Services

Time to integrate this into Routine Survivorship Care @roinnslainte.bsky.social @cancertrialsie.bsky.social
Reposted by Séamus O’Reilly MDPhD
eaonc.bsky.social
Congratulations to the 2025 #EAOnc Remarkable Mentor in Oncology Award recipient, Dr. Joan Schiller of @lungcancerresearch.bsky.social @ouchinternational.bsky.social! #mentorship #LungCancer
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
Ahead of the Cancer Retreat this Friday, we want to take a moment to celebrate to our outgoing CEO, @eibhlinmulroe.bsky.social .

Her passion, vision & advocacy for cancer clinical trials have shaped who we are today.

Thank you, Eibhlín, for everything. 💛
🎥 Watch the memories.
Reposted by Séamus O’Reilly MDPhD
cancertrialsie.bsky.social
The 2025 National Training Day report is now live.

A showcase of early-career research, mentorship, collaboration & innovation in cancer clinical trials.

Hosted by Cancer Trials Ireland & ISMO, sponsored by @daiichisankyo.bsky.social

Read it here: bit.ly/4kgATpp

#CancerT#CancerTrials5#NTD2025g#Oncology
seamusoreilly.bsky.social
The growing impact of climate change 🔥🌪️⛈️🌊☀️ on how we conduct trials & the multiple opportunities for ♻️sustainability in our community.
Grateful to 🏴󠁧󠁢󠁷󠁬󠁳󠁿🇬🇧🇧🇪🇮🇪🇸🇪🇬🇷🇧🇷🏴󠁧󠁢󠁳󠁣󠁴󠁿 co authors & @bigxresearch.bsky.social members who completed the survey
Responding BIG member locations Areas where climate change affected trial conduct up to March 2024
Reposted by Séamus O’Reilly MDPhD
ouchinternational.bsky.social
Cancer care’s climate cost is rising. 🌍
Dr. Emer Lynch & team, with OUCH’s Dr. Seamus O'Reilly as senior author, outlines key steps forward in JCO Oncology Practice. Editorial by Dr. Peppercorn calls for urgent action.

Read: doi.org/10.1200/OP-2...
Editorial: doi.org/10.1200/OP-2...
#GreenOncology
Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care | JCO Oncology Practice
doi.org